These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 23760807)
1. Disulfide bonds in amyloidogenesis diseases related proteins. Li Y; Yan J; Zhang X; Huang K Proteins; 2013 Nov; 81(11):1862-73. PubMed ID: 23760807 [TBL] [Abstract][Full Text] [Related]
2. The role of intra and inter-molecular disulfide bonds in modulating amyloidogenesis: A review. Mitra A; Sarkar N Arch Biochem Biophys; 2022 Feb; 716():109113. PubMed ID: 34958750 [TBL] [Abstract][Full Text] [Related]
3. Exploring critical determinants of protein amyloidogenesis: a review. Sarkar N; Dubey VK J Pept Sci; 2013 Sep; 19(9):529-36. PubMed ID: 23873708 [TBL] [Abstract][Full Text] [Related]
4. Dissecting the role of disulfide bonds on the amyloid formation of insulin. Li Y; Gong H; Sun Y; Yan J; Cheng B; Zhang X; Huang J; Yu M; Guo Y; Zheng L; Huang K Biochem Biophys Res Commun; 2012 Jun; 423(2):373-8. PubMed ID: 22664107 [TBL] [Abstract][Full Text] [Related]
5. Protein denaturation and aggregation: Cellular responses to denatured and aggregated proteins. Meredith SC Ann N Y Acad Sci; 2005 Dec; 1066():181-221. PubMed ID: 16533927 [TBL] [Abstract][Full Text] [Related]
6. The dissociated form of kappa-casein is the precursor to its amyloid fibril formation. Ecroyd H; Thorn DC; Liu Y; Carver JA Biochem J; 2010 Jul; 429(2):251-60. PubMed ID: 20441567 [TBL] [Abstract][Full Text] [Related]
7. Cys-10 mixed disulfide modifications exacerbate transthyretin familial variant amyloidogenicity: a likely explanation for variable clinical expression of amyloidosis and the lack of pathology in C10S/V30M transgenic mice? Zhang Q; Kelly JW Biochemistry; 2005 Jun; 44(25):9079-85. PubMed ID: 15966731 [TBL] [Abstract][Full Text] [Related]
8. Structure-based design and study of non-amyloidogenic, double N-methylated IAPP amyloid core sequences as inhibitors of IAPP amyloid formation and cytotoxicity. Kapurniotu A; Schmauder A; Tenidis K J Mol Biol; 2002 Jan; 315(3):339-50. PubMed ID: 11786016 [TBL] [Abstract][Full Text] [Related]
9. Sequence and structure-based peptides as potent amyloid inhibitors: A review. Mitra A; Sarkar N Arch Biochem Biophys; 2020 Nov; 695():108614. PubMed ID: 33010227 [TBL] [Abstract][Full Text] [Related]
10. Amyloid peptides and proteins in review. Harrison RS; Sharpe PC; Singh Y; Fairlie DP Rev Physiol Biochem Pharmacol; 2007; 159():1-77. PubMed ID: 17846922 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins. Guerrero-Muñoz MJ; Castillo-Carranza DL; Kayed R Biochem Pharmacol; 2014 Apr; 88(4):468-78. PubMed ID: 24406245 [TBL] [Abstract][Full Text] [Related]
12. Beyond amino acid sequence: disulfide bonds and the origins of the extreme amyloidogenic properties of insulin's H-fragment. Dec R; Koliński M; Dzwolak W FEBS J; 2019 Aug; 286(16):3194-3205. PubMed ID: 30980592 [TBL] [Abstract][Full Text] [Related]
13. A highly amyloidogenic region of hen lysozyme. Frare E; Polverino De Laureto P; Zurdo J; Dobson CM; Fontana A J Mol Biol; 2004 Jul; 340(5):1153-65. PubMed ID: 15236974 [TBL] [Abstract][Full Text] [Related]
14. Effect of the disulfide bond on the monomeric structure of human amylin studied by combined Hamiltonian and temperature replica exchange molecular dynamics simulations. Laghaei R; Mousseau N; Wei G J Phys Chem B; 2010 May; 114(20):7071-7. PubMed ID: 20429571 [TBL] [Abstract][Full Text] [Related]
15. Amyloidogenicity of p53: a hidden link between protein misfolding and cancer. Gong H; Yang X; Zhao Y; Petersen RB; Liu X; Liu Y; Huang K Curr Protein Pept Sci; 2015; 16(2):135-46. PubMed ID: 25692950 [TBL] [Abstract][Full Text] [Related]
16. Implications of protein structure instability: from physiological to pathological secondary structure. Sukhanova A; Poly S; Shemetov A; Bronstein I; Nabiev I Biopolymers; 2012 Aug; 97(8):577-88. PubMed ID: 22605549 [TBL] [Abstract][Full Text] [Related]
17. Induction of beta-sheet structure in amyloidogenic peptides by neutralization of aspartate: a model for amyloid nucleation. Orpiszewski J; Benson MD J Mol Biol; 1999 Jun; 289(2):413-28. PubMed ID: 10366514 [TBL] [Abstract][Full Text] [Related]
18. Cys10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Zhang Q; Kelly JW Biochemistry; 2003 Jul; 42(29):8756-61. PubMed ID: 12873136 [TBL] [Abstract][Full Text] [Related]
19. A disulfide-linked amyloid-beta peptide dimer forms a protofibril-like oligomer through a distinct pathway from amyloid fibril formation. Yamaguchi T; Yagi H; Goto Y; Matsuzaki K; Hoshino M Biochemistry; 2010 Aug; 49(33):7100-7. PubMed ID: 20666485 [TBL] [Abstract][Full Text] [Related]
20. Runaway domain swapping in amyloid-like fibrils of T7 endonuclease I. Guo Z; Eisenberg D Proc Natl Acad Sci U S A; 2006 May; 103(21):8042-7. PubMed ID: 16698921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]